|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - New approaches to influenza prevention and treatment - lessons learnt from COVID- 19
Flu is the forgotten killer. What new vistas of vaccinology opened up after the COVID-19 pandemic? In what ways can flu treatments change as a consequence of lessons learned?
|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - Travel preparedness and vaccinations
How has the world of travel medicine evolved? What multiple roles do vaccinations have? What impact did the COVID-19 pandemic have on travel behaviour? Why is it so important to keep up to date on the current epidemiological situation?
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism
Research shows that the procoagulant state of PBMC could aid in the early detection of PE in COVID-19 ICU patients. When combined with the end-tidal to ETCO2 – PaCO2 gradient, these tests could improve the early detection of PE in the ICU.
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
Infants younger than 6 months are at risk of severe SARS-CoV-2 infection.
High number of HPAI H5 virus infections and antibodies in wild carnivores in the Netherlands, 2020–2022
Wild birds, particularly those belonging to the orders Anseriformes and Charadriiformes, are the natural host of a wide range of low pathogenicity avian influenza (LPAI) viruses.
A Fragile State of Preparedness: 2023 Report on the State of the World's Preparedness
The Global Preparedness Monitoring Board (GPMB) 2023 Report points out that global preparedness for pandemics and other disease outbreaks remains inadequate, making four key recommendations to urgently strengthen global preparedness.
The European Respiratory Virus Surveillance Summary (ERVISS)
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and severe acute respiratory syndrome coronavirus 2 for the EU/EEA and the WHO European Region
How the current bird flu strain evolved to be so deadly
Genetic changes to avian influenza viruses have led to spread among many wild species, creating an uncontrollable global outbreak.
The episodic resurgence of highly pathogenic avian influenza H5 virus
Highly pathogenic avian influenza (HPAI) H5N1 activity has intensified globally since 2021, increasingly causing mass mortality in wild birds and poultry and incidental infections in mammals.
EU Countries miss flu vaccination target (except for one)
European health ministers agreed on a target of vaccinating 75% of older people in 2009 ‒ almost all countries are still falling short.
